SaigonBao.com

Archive -Daily News

CRISPR Therapy

CRISPR : 2023December18Monday

CRISPR Therapeutics Just Made History. So Why Did Its Stock Fall? - Yahoo Finance

The era of CRISPR therapeutics is here – what can we expect? | Explained - The Hindu

Sickle Cell CRISPR Therapy May Offer 'Functional Cure' - Medscape

Vertex-CRISPR’s Casgevy Gets Positive EMA Panel Opinion, Approval Decision in Q1 2024 - BioSpace

Charles River snags clearance to produce Vertex and CRISPR's Casgevy from Tennessee plant - FiercePharma

Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy - Yahoo Finance

A genome-wide CRISPR/Cas9 screen identifies a role for Rab5A and early endosomes in hepatitis E virus replication ... - pnas.org

FDA Approves Cure for Sickle Cell Disease, the First Treatment to Use Gene-Editing Tool CRISPR - Good News Network

Here's the 1 Key Reason You Might Want to Buy CRISPR Therapeutics Stock on the Dip - Yahoo Finance

CRISPR 2.0: a new wave of gene editors heads for clinical trials - Nature.com

Genetic Engineering: 2023December18Monday

The Landscape of Agricultural Biotechnology - Technology Networks

In a World First, a Patient's Antibody Cells Were Just Genetically Engineered - WIRED

USDA Deregulates Corn Developed Using Genetic Engineering - USDA APHIS

Researchers Discover Natural Gene Therapy System in Mice - Inside Precision Medicine

CRISPR opens doors for novel probiotic functions and applications - News-Medical.Net

A thermostable type I-B CRISPR-Cas system for orthogonal and multiplexed genetic engineering - Nature.com

Tome Biosciences Raises $213M to Commercialize MIT Developed Genome Editing Tech - Genetic Engineering & Biotechnology News

Gene editing based on CRISPR may treat SMA via SMN2 gene - SMA News Today

Build Scientific Understanding of Genetic Engineering with High School Students | Extension News - University of Connecticut

The Gamble: Can Genetically Modified Mosquitoes End Disease? - The New York Times

Gene Editing : 2023December18Monday

Prime Medicine, Myeloid Therapeutics clash over genome-editing deal - STAT

FDA Approves Cure for Sickle Cell Disease, the First Treatment to Use Gene-Editing Tool CRISPR - Good News Network

Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment - NPR

‘Remarkable’ gene-editing treatment for sickle cell disease is approved by FDA - Fox News

CRISPR 2.0: a new wave of gene editors heads for clinical trials - Nature.com

FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease - Scientific American

Crispr Whipsaws Lower After FDA OKs Gene-Editing Treatment - Investor's Business Daily

U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease - CNBC

I received the new gene-editing drug for sickle-cell disease. It changed my life. - MIT Technology Review

Landmark gene-editing therapy approved: here's what you need to know - POLITICO

CRISPR Therapy : 2023December18Monday

Vertex (VRTX), CRISPR Get Positive CHMP Opinion for Gene-Therapy - Yahoo Finance

Sickle Cell CRISPR Therapy May Offer 'Functional Cure' - Medscape

F.D.A. Approves 2 Sickle Cell Treatments, One Using CRISPR Gene Editing - The New York Times

The first CRISPR therapy approved in the U.S. will treat sickle cell disease - Science News Magazine

1st gene therapies for sickle cell cleared by FDA, including CRISPR treatment - Livescience.com

Questions and answers on Casgevy, a new CRISPR-based therapy - STAT

UK first to approve CRISPR treatment for diseases: what you need to know - Nature.com

FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR - NBC News

FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease - Scientific American

US FDA approves two gene therapies for sickle cell disease - Reuters